All News

Check out these important FDA updates from the month of October 2024.

Presenters at the National Community Pharmacists Association 2024 Annual Convention and Expo discussed workflow and the future of pharmacy as a patient destination.

Researchers conducted a systematic review of randomized trials to determine the efficacy of ketamine for patients with cancer.

Hurricane season brings extreme weather and health care disruptions, emphasizing the importance of medication preparedness for patients and pharmacists.

A conversation with David Ha, PharmD, BCIDP, at the National Community Pharmacists Association 2024 Annual Convention and Expo.

GoodRx’s new e-commerce service further expands access to Opill by allowing consumers to order the birth control directly to their homes without a prescription.

Ian Stone, Senior Vice President at Mesmerize, discussed the essential aspects of a community pharmacy and how his company can help independent owners excel in the future.

Lisa Faast, PharmD, Founder and CEO of Diversify Rx, discussed how technology is used to innovate within the pharmacy.

Women experiencing later menopause may face a heightened risk of asthma, underscoring the possible role of estrogen in the development of the condition.

Researchers addressed the gut-first hypothesis of Parkinson disease by identifying how mucosal damage impacts risk of development.

Timothy Aungst, PharmD, Founder of The Digital Apothecary, discussed advancements in digital health and what to be aware of regarding the future of technology.

Trent Thiede, PharmD, MBA, president of PAAS National, discusses best practices that pharmacy teams can implement to proactively prevent audit issues before they arise.

Scott Biggs, Director of Supplier Services at IQVIA, discussed pharmacy trends within the industry and how pharmacists can stay ahead of them.

Johnson & Johnson announced results from its phase 3 GRAVITI trial exploring guselkumab’s results in subcutaneous (SC) induction and maintenance therapy for treating Crohn’s disease.

A.J. Lipka, Business Development Lead of Network Growth at Outcomes, discussed the impact of pharmacy-sponsored programming.

The addition of a 10 mg oxycodone hydrochloride tablet improves dosing flexibility and precision.

At the NCPA 2024 Annual Convention and Expo, Drug Topics asked different pharmacists what they think the importance of the conference is to the independent pharmacy community.

Melody Hartzler, PharmD, discusses common metabolic roadblocks to weight loss and what tools pharmacy teams can use to identify and address them.

A conversation with Sean Jeffery, PharmD, BCGP, FASCP, AGSF, director of pharmacy at Hartford HealthCare Integrated Care Partners and professor of pharmacy practice at the University of Connecticut.

Researchers analyzed the lack of prevention and treatment options for managing drug-induced liver injury.

With nearly 7 million women living in a health care desert, pharmacists can provide crucial reproductive care services.

Don’t miss out on the latest pharmacy insights in the Drug Topics September/October issue.

The NCPA 2024 Annual Convention and Expo runs through October 29, 2024, in Columbus, Ohio.

Before marketing your pharmacy’s immunizations services, check out these takeaways from NCPA.

A conversation with Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic.

Industry experts gathered to discuss pharmacy benefit managers, their current grasp on the drug supply chain, and how it all impacts independent pharmacies.

PBM reform legislation has progressed further in Congress than ever before.

A conversation with Erin Rexroth, director of marketing at the National Community Pharmacists Association.